Bernhard O. Boehm
Department of Internal Medicine I
University Hospital
Ulm Medical School
Germany
Name/email consistency: high
- The metabolic syndrome. Boehm, B.O., Claudi-Boehm, S. Scand. J. Clin. Lab. Invest. Suppl. (2005)
- Prevalence of the metabolic syndrome in southwest Germany. Boehm, B.O., Claudi-Boehm, S., Yildirim, S., Haenle, M.M., Hay, B., Mason, R.A., Steinbach, G., Koenig, W., Kern, P., März, W., Kratzer, W. Scand. J. Clin. Lab. Invest. Suppl. (2005)
- Elevated serum levels of N(epsilon)-carboxymethyl-lysine, an advanced glycation end product, are associated with proliferative diabetic retinopathy and macular oedema. Boehm, B.O., Schilling, S., Rosinger, S., Lang, G.E., Lang, G.K., Kientsch-Engel, R., Stahl, P. Diabetologia (2004)
- Low content of the natural ocular anti-angiogenic agent pigment epithelium-derived factor (PEDF) in aqueous humor predicts progression of diabetic retinopathy. Boehm, B.O., Lang, G., Volpert, O., Jehle, P.M., Kurkhaus, A., Rosinger, S., Lang, G.K., Bouck, N. Diabetologia (2003)
- The therapeutic potential of somatostatin receptor ligands in the treatment of obesity and diabetes. Boehm, B.O. Expert. Opin. Investig. Drugs (2003)
- Octreotide reduces vitreous hemorrhage and loss of visual acuity risk in patients with high-risk proliferative diabetic retinopathy. Boehm, B.O., Lang, G.K., Jehle, P.M., Feldman, B., Lang, G.E. Horm. Metab. Res. (2001)